soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 found to lower risk of heart failure events in people with type 2 diabetes Oral Semaglutide Lowers Cardiovascular Events

If you have Type 2 diabetes, the medications help manage your blood sugar by triggering your pancreas to release more insulin

[1] [12] Given the growing prevalence of type 2 diabetes and obesity in the United States, tirzepatide has become an important therapeutic option for millions of patients

In contrast, greater reductions in waist circumference at week 20 were associated with a lower subsequent risk of MACE

Broader Implications This shift has altered perceptions of healthy weight management

The face loses fat volume alongside the rest of the body, and because facial fat is structural, its loss has consequences that are immediately visible

It is important to be well informed of the possible side effects prior to starting any steroid medication, including the impact it may have on your diabetes